SYNthesis BioVentures and AdAlta Collaborate to Enhance Cancer Immunotherapy
#industry #news #UK #2024 #insights #zenopa #recruitment #SYNthesis #BioVentures #AdAlta #Collaborate #Enhance #Cancer #Immunotherapy #pharmaceutical
Source: zenopa.com
Tim Oldham News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tim Oldham Today - Breaking & Trending Today
Biotech stocks weather down market; showing solid signs of recovery
It’s been a difficult quarter for the biotech sector, with economies struggling to recover from high inflation making for a small appetite for risk. The ASX...
Source: proactiveinvestors.com.au
AdAlta raises $1.65 million in oversubscribed placement to support clinical study and partner discussions
Clinical-stage drug discovery company AdAlta Ltd (ASX:1AD) has raised $1.65 million in an oversubscribed placement to institutional and sophisticated...
Source: proactiveinvestors.com.au
AdAlta to raise $1.2 million to advance AD-214 clinical analysis and progress partnership talks
AdAlta Ltd (ASX:1AD) has launched a placement to sophisticated and professional investors to raise up to A$1.23 million at an issue price of 2 cents per new...
Source: proactiveinvestors.com.au
AdAlta making material progress on partnering talks
AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after announcing all healthy volunteers in its AD-214 Phase I extension study have successfully...
Source: proactiveinvestors.com.au